Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2013-10-25

European Medicines Agency advises on compassionate use of sofosbuvir

View source ↗

Summary

EMA provides guidance on compassionate use of sofosbuvir, outlining how it can be accessed in certain circumstances outside of approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sofosbuvir (sofosbuvir)